Lv61
2636 积分 2022-05-04 加入
Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies
2小时前
已完结
Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors
2小时前
已完结
Generating potent and persistent antitumor immunity via affinity-tuned CAR-T cells targeting mesothelin
2小时前
已完结
Senolytic CAR T cells reverse senescence-associated pathologies
8天前
已完结
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target
8天前
已完结
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy
19天前
已完结
Primary cilia abnormalities participate in the occurrence of spontaneous abortion through TGF‐β/SMAD2/3 signaling pathway
1个月前
已完结
Targeting uPAR-Positive Tumor and Stroma Enhances CAR T-Cell Efficacy
1个月前
已关闭
CAR-neutrophils produced in vivo to treat glioma
2个月前
已完结
皖公网安备34019202002308
